About Sinocare
Sinocare Inc. is a Chinese medical technology company specializing in diabetes management and chronic disease monitoring. Founded in 2002 and headquartered in Changsha, Hunan Province, China, the company develops, manufactures, and markets blood glucose monitoring systems, continuous glucose monitoring (CGM) devices, blood pressure monitors, uric acid meters, cholesterol testing systems, and other rapid diagnostic products. Sinocare is one of the world’s largest manufacturers of blood glucose monitoring devices and describes itself as “The Leading Diabetes Digital Management Expert in the World.” [1]
History
Sinocare was established in 2002 with the mission of making blood glucose monitoring more affordable and accessible for people with diabetes in China. The company initially focused on developing home-use blood glucose meters and testing strips.
Over the following years, Sinocare expanded its research and manufacturing capabilities, becoming one of China’s leading providers of diabetes monitoring products. The company was also recognized as China’s first publicly listed blood glucose meter company.
A major milestone occurred in 2016, when Sinocare acquired Trividia Health Inc. (formerly Nipro Diagnostics Inc.) and PTS Diagnostics Inc. in the United States. These acquisitions significantly expanded the company’s international presence and strengthened its position in the global diagnostics industry. [2]
Business Overview
Sinocare operates as a high-tech healthcare company focused on:
-
Diabetes management
-
Chronic disease monitoring
-
Point-of-care diagnostic testing
-
Digital healthcare solutions
-
Biosensing technology
The company integrates medical devices with digital platforms to support long-term disease management for both patients and healthcare professionals. Its digital ecosystem combines biosensors, Internet of Things (IoT) technologies, smart healthcare services, and health management applications. [3]
Products
Sinocare manufactures a wide range of healthcare devices, including:
Blood Glucose Monitoring
-
Blood glucose meters
-
Blood glucose test strips
-
Lancets and lancing devices
-
Control solutions
Continuous Glucose Monitoring (CGM)
-
Wearable CGM sensors
-
Mobile monitoring applications
-
Real-time glucose tracking systems
Blood Pressure Monitoring
-
Automatic upper-arm blood pressure monitors
-
Home blood pressure management devices
Multiparameter Testing
-
Uric acid meters
-
Cholesterol testing systems
-
Hemoglobin testing products
-
Ketone testing products
Hospital and Professional Diagnostics
-
Point-of-care diagnostic analyzers
-
Clinical laboratory testing systems
-
Professional diabetes management solutions [4]
Global Presence
According to the company, Sinocare has:
-
9 global research and manufacturing sites
-
Products available in 187 countries and regions
-
More than 25 million users worldwide
-
A position as the No. 1 blood glucose monitoring brand in China
-
A ranking among the top four blood glucose monitoring companies globally by its own reported market position. [5]
Research and Innovation
Sinocare invests heavily in biosensor technology and chronic disease management. Its research focuses on:
-
Continuous glucose monitoring
-
Biosensing technologies
-
Artificial intelligence for diabetes management
-
Smart healthcare platforms
-
Remote patient monitoring
The company holds more than 780 authorized patents, according to its official information. [6]
Mission and Vision
Mission
Guided by love, with a commitment to global access and health outcomes, Sinocare delivers innovative, high-quality solutions for people living with diabetes and related chronic diseases.
Vision
To become the Leading Diabetes Digital Management Expert in the World.
Its stated core values emphasize commitment to customers, employees, partners, society, and shareholders. [7]
Markets
Sinocare serves multiple customer groups, including:
-
Individuals managing diabetes at home
-
Hospitals and clinics
-
Healthcare professionals
-
Pharmacies
-
Public health organizations
Its products are distributed throughout Asia, Europe, North America, South America, the Middle East, and Africa. [8]
Recent Developments
Sinocare continues to expand its digital healthcare portfolio, particularly in continuous glucose monitoring (CGM). The company has introduced new CGM technologies featuring extended sensor wear, AI-assisted glucose analytics, and integrated mobile health applications, while also showcasing broader digital health solutions at major international medical exhibitions. [9]
Summary
Sinocare has grown from a domestic Chinese blood glucose meter manufacturer into an international medical technology company focused on diabetes and chronic disease management. Its portfolio spans traditional blood glucose meters, wearable CGM systems, blood pressure monitors, diagnostic analyzers, and digital healthcare platforms. Through continued investment in biosensing technology and international expansion, the company has established a presence in more than 180 countries and serves millions of users worldwide. [10]
References
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website
-
Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand – Sinocare Official Website





